Jiamian Zheng
Key Laboratory For Regenerative Medicine Of Ministry Of Education
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Highly suppressive functional CCR7 low Treg subset cells may correlate with poor prognosis of B-ALL.
Highly suppressive functional CCR7 low Treg subset cells may correlate with poor prognosis of B-ALL.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 28, 2026
Impact of G-CSF on Donor TCR Clonal Diversity and T Cell Function During Donor HSC Mobilisation.
Journal: Cell proliferation
Published: December 22, 2025
High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8+ T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients.
Journal: International journal of immunopathology and pharmacology
Published: June 16, 2025
Gene Signature-Based Prognostic Model for Acute Myeloid Leukemia: The Role of BATF, EGR1, PD-1, PD-L1, and TIM-3.
Journal: International journal of medical sciences
Published: December 10, 2024
Analysis of prognostic biomarker models of TXNIP/NLRP3/IL1B inflammasome pathway in patients with acute myeloid leukemia.
Journal: International journal of medical sciences
Published: March 25, 2024
Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.
Journal: Frontiers in immunology
Published: October 10, 2023
Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis.
Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis.
Journal: Experimental hematology & oncology
Published: December 24, 2022
The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy.
Journal: Frontiers in immunology
Published: November 28, 2022
Increased PD-1+Foxp3+ γδ T cells associate with poor overall survival for patients with acute myeloid leukemia.
Journal: Frontiers in oncology
Published: October 17, 2022
TIGIT axis: novel immune checkpoints in anti-leukemia immunity.
Journal: Clinical and experimental medicine
Published: December 07, 2021
High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia.
Journal: Frontiers in immunology
Published: November 27, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026